Archive: 27/10/2020
Case suggests that nivolumab may be an effective treatment for refractory Burkitt lymphoma
Checkpoint inhibitor nivolumab may be an effective treatment for refractory Burkitt lymphoma, a rare and aggressive form of cancer. This is an important development for patients whose cancer cells remain resistant to usual ...
Oct 27, 2020